Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypertension and Regulation of Blood Pressure

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

Hypertension I: Introduction

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Myeloid transglutaminase 2 regulates Treg-Th17 balance in a female model of angiotensin II-induced hypertension and vascular stiffening.

American journal of physiology. Heart and circulatory physiology·2026

Same author

Vascular Smooth Muscle Cell TG2 Promotes DOCA/Salt-Induced Arterial Stiffness and Hypertension.

Hypertension (Dallas, Tex. : 1979)·2025

Same author

Prevention of cardiovascular disease in women with type 2 diabetes: the role of incretin mimetics and sodium-glucose cotransporter-2 inhibitors.

American journal of physiology. Cell physiology·2024

Same author

Enhanced ECCD36 signaling promotes skeletal muscle insulin resistance in female mice.

American journal of physiology. Endocrinology and metabolism·2024

Same author

The mineralocorticoid receptor in diabetic kidney disease.

American journal of physiology. Renal physiology·2024

Same author

Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH.

Journal of hepatology·2024

Search research articles

Related Experiment Video

Updated: May 30, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Hypertension in obesity.

L Romayne Kurukulasuriya¹, Sameer Stas, Guido Lastra

¹Department of Internal Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO 65212, USA. romaynel@health.missouri.edu

The Medical Clinics of North America

|August 23, 2011

Summary

Obesity and hypertension (HTN) are global health issues. Treating HTN to goal and preventing obesity are crucial for managing cardiovascular disease and chronic kidney disease consequences.

Related Experiment Videos

Last Updated: May 30, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Area of Science:

Cardiology
Endocrinology
Nephrology

Background:

Hypertension (HTN) is a prevalent obesity-related health problem, with visceral obesity being a significant contributor.
A low percentage (31%) of hypertensive patients achieve treatment goals, leading to increased cardiovascular disease (CVD) morbidity and mortality.
Obesity-related HTN involves complex, interrelated mechanisms including RAAS activation, SNS, insulin resistance, and hormonal imbalances.

Purpose of the Study:

To review the mechanisms underlying obesity-related hypertension.
To discuss current and potential therapeutic strategies for managing hypertension in obese individuals.
To emphasize the importance of weight management and blood pressure control.

Main Methods:

Literature review of studies on obesity-related hypertension mechanisms and treatments.
Analysis of postulated factors contributing to obesity-induced HTN.
Evaluation of current treatment guidelines and research trials.

Main Results:

Several factors contribute to obesity-related HTN, including RAAS and SNS activation, insulin resistance, and hormonal dysregulation.
Current evidence does not strongly favor one antihypertensive drug class over another for obese patients.
Obesity management through lifestyle changes, medication, or bariatric surgery is essential.

Conclusions:

Effective management of obesity-related HTN requires a multifaceted approach.
Preventing and treating obesity, alongside achieving blood pressure goals, is paramount.
Further research is needed to elucidate specific mechanisms and targeted treatments for obesity-related HTN.